However, this method can suppress anti-tumor immunity by reducing peripheral and tumor-infiltrating effector immune subsets, increasing immunosuppressive cell subsets, and restraining PD-1/PD-L1 expression in the TME [25]. This evidence concerns the gene PDCD1 and neoplasm.